Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

COLL

Collegium Pharmaceutical (COLL)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:COLL
DataOraFonteTitoloSimboloCompagnia
10/01/202522:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
08/01/202514:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
08/01/202514:00GlobeNewswire Inc.Collegium Provides 2025 Financial Guidance and Business UpdateNASDAQ:COLLCollegium Pharmaceutical Inc
14/11/202422:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
14/11/202422:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
12/11/202414:00GlobeNewswire Inc.Collegium to Participate in Upcoming Investor ConferencesNASDAQ:COLLCollegium Pharmaceutical Inc
07/11/202422:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COLLCollegium Pharmaceutical Inc
07/11/202422:02GlobeNewswire Inc.Collegium Reports Record Third Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
07/11/202422:01GlobeNewswire Inc.Collegium Appoints Vikram Karnani as Chief Executive OfficerNASDAQ:COLLCollegium Pharmaceutical Inc
24/10/202414:00GlobeNewswire Inc.Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
30/08/202414:00GlobeNewswire Inc.Collegium to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:COLLCollegium Pharmaceutical Inc
28/08/202414:00GlobeNewswire Inc.Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024NASDAQ:COLLCollegium Pharmaceutical Inc
15/08/202422:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:COLLCollegium Pharmaceutical Inc
08/08/202422:01GlobeNewswire Inc.Collegium Reports Second Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
29/07/202412:00GlobeNewswire Inc.Collegium to Acquire Ironshore Therapeutics, Expanding into NeurologyNASDAQ:COLLCollegium Pharmaceutical Inc
25/07/202414:00GlobeNewswire Inc.Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
13/06/202414:00GlobeNewswire Inc.Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta FranchiseNASDAQ:COLLCollegium Pharmaceutical Inc
29/05/202417:19Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:COLLCollegium Pharmaceutical Inc
29/05/202414:00GlobeNewswire Inc.Collegium to Participate in Jefferies Global Healthcare ConferenceNASDAQ:COLLCollegium Pharmaceutical Inc
13/05/202414:00GlobeNewswire Inc.Collegium Announces $35 Million Accelerated Share Repurchase ProgramNASDAQ:COLLCollegium Pharmaceutical Inc
10/05/202414:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:COLLCollegium Pharmaceutical Inc
09/05/202422:02GlobeNewswire Inc.Collegium Reports First Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
09/05/202422:01GlobeNewswire Inc.Collegium Announces CEO TransitionNASDAQ:COLLCollegium Pharmaceutical Inc
29/04/202414:00GlobeNewswire Inc.Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ERNASDAQ:COLLCollegium Pharmaceutical Inc
25/04/202414:00GlobeNewswire Inc.Collegium to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
11/04/202414:00GlobeNewswire Inc.Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026NASDAQ:COLLCollegium Pharmaceutical Inc
03/04/202414:00GlobeNewswire Inc.Collegium to Participate in 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:COLLCollegium Pharmaceutical Inc
22/02/202422:09GlobeNewswire Inc.Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
22/02/202422:03Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:COLLCollegium Pharmaceutical Inc
14/02/202418:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:COLLCollegium Pharmaceutical Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:COLL
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network